EU to terminate vaccine agreement with Valneva
A lacking marketing approval has allowed the European Commission to terminate its Covid-19 vaccine purchasing agreement with Valneva.
by marketwire, translated by daniel pedersen
On Monday, French vaccine maker Valneva is being punished by investors on the Paris stock exchange following news that the EU is intending to terminate its purchasing agreement on Covid-19 vaccines.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
